TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,265.00
-130.00 (-5.43%)
Oct 8, 2026, 3:30 PM KST

TELCON RF PHARMACEUTICAL. Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-17,481-11,456-26,32013,906-42,084-23,098
Depreciation & Amortization
5,9044,8244,5074,2444,2814,200
Loss (Gain) From Sale of Assets
-234.82-486.92-17.2714.8-34.38250.45
Asset Writedown & Restructuring Costs
1,3241,3241,09764.84,4113,005
Loss (Gain) From Sale of Investments
41,3105,817-1,275-13,46613,146-4,626
Loss (Gain) on Equity Investments
-2,6993,70924,684-469.5317,86813,196
Stock-Based Compensation
330.87-----
Provision & Write-off of Bad Debts
164.91-417.28206.34251.8746.56-19.19
Other Operating Activities
-23,2971,041618.75963.052,6487,383
Change in Accounts Receivable
-4,237-2,958-3,908-6,563-1,450-791.38
Change in Inventory
1,084-1,119528.74-717.74-1,684-677.17
Change in Accounts Payable
251.751,1451,572503.37646.5260.21
Change in Other Net Operating Assets
-547.9242.36-474.55133.25-586.66758.06
Operating Cash Flow
1,8721,6671,219-1,135-2,093-358.56
Operating Cash Flow Growth
-36.73%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,825-319.81-4,968-3,820-819.43-2,254
Sale of Property, Plant & Equipment
97.41-18.055.8866.8160.24
Cash Acquisitions
-30.98-30.98----
Divestitures
12,904505.56----
Sale (Purchase) of Intangibles
186.43--7.13-18-14.52-3,559
Investment in Securities
-4,2666,401-44,536419.38-7,0826,508
Other Investing Activities
34.44194.3838.83-32.3246.34124.26
Investing Cash Flow
-1,002-1,345-44,084-10,525-7,885879.02

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2,80036,600-200-
Long-Term Debt Issued
-11,88029,78013,1081,000-
Total Debt Issued
1,47614,68066,38013,1081,200-
Short-Term Debt Repaid
--19,400-18,000-200--
Long-Term Debt Repaid
--12,715-10,737-2,947-4,640-1,922
Total Debt Repaid
-27,532-32,115-28,737-3,147-4,640-1,922
Net Debt Issued (Repaid)
-26,057-17,43537,6439,961-3,440-1,922
Issuance of Common Stock
40,19340,193----
Other Financing Activities
-418.72-252.598.55484.74-31.01
Financing Cash Flow
13,70722,50537,65110,445-3,440-1,891

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
20.21-7.650.6-0.46-43.3224.42
Miscellaneous Cash Flow Adjustments
0-----
Net Cash Flow
14,59722,819-5,213-1,214-13,462-1,346

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
47.071,347-3,749-4,954-2,912-2,613
Free Cash Flow Growth
------
Free Cash Flow Margin
0.08%3.12%-9.90%-13.64%-10.46%-6.90%
Free Cash Flow Per Share
7.70280.76-1056.80-1104.29-706.88-991.33
Levered Free Cash Flow
-17,548-8,88610,349-5,322316-7,715
Unlevered Free Cash Flow
-15,078-5,87812,699-4,945980.21-2,901

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,7772,0651,304553.73861.42,419
Cash Income Tax Paid
--213.9200.0145.14-27.440.1
Change in Working Capital
-3,449-2,689-2,282-6,644-3,074-650.28